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The study involves the condensation of acylimidazole derivatives of acaclofenac 
(AC) with dextran 10,000 and 20,000 to obtain aceclofenac-dextran prodrugs 
AC10 and AC20 respectively with an aim to improve aqueous solubility, 
increase therapeutic efficiency and reduce the gastrointestinal side effects. The 
structure of synthesized prodrugs was confirmed by IR and NMR spectroscopy. 
The molecular weight was determined by Mark-Howink Sakurada equation 
and the degree of substitution was obtained as 13.3 and 16 % for the prodrugs. 
In vitro hydrolysis carried out in simulated gastric fluid (SGF), simulated 
intestinal fluid (SIF) and simulated colonic fluid (SCF) showed faster hydrolysis 
in SIF and SCF. The percentage anti-inflammatory activity of AC was found as 
49.56 whereas an improved value of 56.44 and 61.82 % were obtained for AC10 
and AC20 respectively. The prodrugs showed improved analgesia and reduced 
ulcerogenicity than aceclofenac, thereby proving to be better in action than the 
parent drug.




El estudio se centra en la condensación de acilimidazoles derivados de 
aceclofenaco (AC) con dextrano 10.000 y 20.000 para obtener los profármacos 
de aceclofenaco-dextrano AC10 y AC20, respectivamente, con el objetivo de 
mejorar la hidrosolubilidad, aumentar la eficacia terapéutica y reducir los efectos 
secundarios gastrointestinales. La estructura de los profármacos sintetizados 
se ha confirmado a través de espectroscopia IR y RMN. El peso molecular 
ha sido determinado a través de la ecuación de Mark-Houwink-Sakurada y 
se ha obtenido un grado de sustitución de 13,3 y 16% para los profármacos. 
La hidrólisis in vitro llevada a cabo en fluido gástrico simulado (FGS), fluido 
intestinal simulado (FIS) y fluido colónico simulado (FCS) ha mostrado una 
hidrólisis más rápida en FIS y FCS. De ello ha resultado un porcentaje de 
actividad antiinflamatoria de AC de 49,56, mientras que para AC10 y AC20 
se ha obtenido un valor aumentado de 56,44 y 61,82% respectivamente. Los 
profármacos han mostrado una mejor analgesia y una menor ulcerogenicidad 
que el aceclofenaco, por lo que se demuestra que su acción es mejor que la del 
fármaco base. 
PALABRAS CLAVE: Aceclofenaco, profármaco polimérico, dextrano, índice de 
úlcera, histología patológica.
INTRODUCTION
Aceclofenac (AC), a potent anti-inflammatory drug, is 
chemically [2-[(2, 6 dichlorophenyl) amino] phenyl] acetyl] 
oxy] acetic acid.1,2 Administration of AC by oral route 
causes many gastrointestinal side effects like nausea, 
vomiting, gastrointestinal irritation, peptic ulceration and 
bleeding, that limit its clinical use. Macromolecules such as 
antibodies, lipoproteins, lectins, proteins, polysaccharides, 
polypeptides, natural as well as synthetic polymers offer 
many applications as high molecular weight carries 
for various therapeutically active compounds. Dextran 
serves as one of the most important polymeric carrier 
for a wide variety of therapeutic agents due to their 
excellent physicochemical properties and physiological 
acceptance.3-5 The pertinent literatures reveal that in most 
of the macromolecular or polymeric prodrug approaches, 
the drug is either linked by physical entrapment or 
chemical linkage to polymeric carriers.6-12 The prodrugs 
with the polymer can temporarily mask the acidic function 
of AC, thereby decreasing its toxicity produced due to the 
direct contact effect with the gastric mucosa. The present 
study deals with the conjugation of dextrans of molecular 
weights 10,000 and 20,000 with aceclofenac to produce 
AC10 and AC20 respectively with an aim to improve its 
physico-chemical properties, therapeutic efficiency and 
reduce GIT side effects. It is equally important to conduct 
a detailed pharmacological study of synthesized prodrugs, 
to bring out some findings that may help in its effective 
use. 
MATERIALS AND METHODS
2.1. Materials and Instruments
The aceclofenac was obtained as gift sample from Alkem 
Laboratories, India. Dextrans of molecular weight 10000 
and 20000, and N, N–carbonyldiimidazole (CDI) was 
purchased from Sigma-Aldrich Chemicals Ltd, USA. 
Silica gel G for TLC was obtained from Sisco Laboratories, 
India. All other solvents and chemicals were of reagent 
grade and obtained from Qualinges Fine Chemicals, India. 
The melting point was recorded using melting point 
determination apparatus by Sigma Instrument, India 
and is uncorrected. The IR spectra were recorded using 
IR spectrophotometer (Shimadzu 8201 PC, Japan) in KBr 
phase in the range 4000 to 400 cm-1. 1H NMR spectra were 
recorded in DMSO on NMR spectrophotometer (Bruker 
DRX 300, USA). Chemical shifts are expressed as δ (ppm) 
values. The degree of substitution and hydrolysis studies 
were determined by Elico UV Spectrophotometer (India).
2.2. Synthesis of dextran prodrugs of aceclofenac
Dextran prodrugs of aceclofenac were prepared by 
first activating the carboxylic acid group using CDI to 
obtain aceclofenac acylimidazole (ADI), which were 
then condensed with dextran of different molecular 
weight (10000 and 20000) in situ to get AC10 and AC20 
respectively13 and is shown in Scheme 1. The progress of 
the reaction was monitored by thin layer chromatography, 
which was performed on silica gel G as stationary phase 
and acetone: chloroform: acetic acid: water in the ratio 
3:2:1:4 as mobile phase. N,N–carbonyldiimidazole is 
moisture-sensitive and, therefore, dry solvents were used 
throughout and anhydrous conditions were maintained 
during the experiment.
The IR and NMR spectral data of AC prodrugs are IR (KBr, 
max cm-1): 1736 (C=O str.), 3070 (C-H str.), 736 (C-H aromatic 
bending), 3421 (-OH str.of polymeric -OH dextran), 1568 
(str. of aromatic ring). 1H NMR (DMSO d6, ppm): 7.27- 
7.52 (m, 8H, aromatic ring), 3.89 (q, 2H, -CH2), 1.46 (t, 3H, 
-CH3), 5.30-3.63 (m, anomeric protons of glucosidic ring), 
2.0- 2.49 (O-H of dextran monomer)
2.3. Characterization of the synthesized prodrugs
2.3.1. Degree of substitution
The degree of substitution of aceclofenac was determined 
by dissolving 20 mg of the dextran prodrug in 20 ml 
solution of phosphate buffer (pH 7.4). The reaction mixture 
was maintained at 70 °C for 1h and left for 24 h for complete 
hydrolysis. It was then neutralized with 1N NaOH. 
The amount of aceclofenac released during hydrolysis 
was extracted with chloroform and determined by UV 
spectrophotometer at the absorption maxima of 230 nm. 
2.3.2. Molecular weight14
Intrinsic viscosities were estimated using Eq. 1. The average 
molecular weights were then calculated by Mark-Howink 
Sakurada equation (Eq 2). 
[η] = [η rel-1] / [c + 0.28 c (η rel-1)]  [1]
log [η] = log K + a log M     [2]
where [η] represents intrinsic viscosity, η rel is the relative 
viscosity at concentration c (%, w/v), M is the molecular 
weight and K and a are the constants.
2.4. In vitro hydrolysis
In-vitro hydrolysis of the dextran prodrugs was studied 
in simulated gastric fluid (SGF) at pH 1.2, in simulated 
intestinal fluid (SIF) at pH 7.4 and in simulated colonic 
fluid (SCF) at pH 6.8. The rate of hydrolysis of the 
dextran prodrugs was computed as the percentage drug 
hydrolysed based on the cumulative amount of drug 
hydrolysed divided by the total amount of drug contained 
in the prodrug. The rate of hydrolysis and half-life of the 
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prepared prodrug were calculated using
r=(2.303/t) log (b/b-x)   [3]
where r represents hydrolysis constant, t is the time in h, 
b is the initial concentration of prodrug, x is the amount of 
prodrug hydrolyzed and (b-x) is the amount of prodrug 
remaining. 
2.5. Pharmacological evaluations 
AC and the synthesized prodrugs were evaluated for 
analgesia, anti-inflammatory activity, ulcerogenicity, 
Scheme 1: Synthesis of Aceclofenac-dextran prodrug
histopathology and a comparative study was performed. 
Test compounds and standard drugs were administered in 
the form of a suspension (1 % carboxy methylcellulose as 
a vehicle) by oral route of administration for analgesic and 
anti-inflammatory studies, but for ulcerogenicity studies 
intra peritoneally as suspension in 2 % (w/v) of acacia. 
Wistar albino rats of three groups, one standard group and 
two test groups, each with six animals were selected. The 
selected animals were housed in acrylic cages at standard 
environmental conditions at 25 ± 2 °C, relative humidity 
of 45–55 %, in a well ventilated room maintained at 12: 
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12 h light: dark cycle, fed with standard rodent diet and 
water ad libitum. All the animals were acclimatized for a 
week before experiment. All animal experiments were 
carried out according to the guidelines of the Committee 
for the Purpose of Control of Experiments on Animals and 
approval of the Institutional Animal Ethics Committee, 
Sree Vidyanikethan College of Pharmacy, Tirupati, India 
was obtained. 
2.5.1. Anti-inflammatory activity
The anti-inflammatory activity was evaluated using 
carrageenan-induced oedema of rat paw.15,16 Albino rats 
(100-200g) were divided into three groups of six animals 
each. Group 1 served as standard group and received 
aceclofenac 2 mg/kg. The group II and group III received 
prodrugs AC10 and AC20 respectively, where the dose 
was molecularly equivalent to the free drug. The initial 
volume of right hind paw of albino rat was measured 
by plethysmometer without administration of drug. The 
drug was administered orally in 1% suspension of sodium 
CMC. After 30 min of drug administration of prodrug, 
carrageenan (0.1 ml, 1%) w/v solution in normal saline 
was injected into the planter surface of right hind paw of 
each animal as phlogistic agent. The volume of right hind 
paw of albino rats was measured after 2, 4 and 6 h. The 
mean difference in the volume of the right hind paw of rats 
was compared with standard. The percent inhibition of 
paw oedema was calculated as
Percent inhibition=(1-Vt/Vc)x100  [5]
where Vc – mean relative change in paw edema volume in 
control group and Vt - mean relative change in paw edema 
volume in test group. 
2.5.2. Analgesic activity
The analgesic activity of synthesized prodrugs was 
determined by thermal stimulus using tail flick method.17 
Analgesiometer was used for the determination of pain 
threshold of albino rats. The rat (100-200 g) was placed in 
a holder through which the tail of the rat was protruded 
out. The reaction time was recorded at 1, 2, 3 and 4 h after 
the treatment and cut-off time was 9 s. The normal reaction 
time, i.e. the time taken to flick the tail was noted. Animals 
showing delayed response were rejected. The prodrug was 
administered orally in 1% suspension of sodium CMC 
and compared with aceclofenac as reference. The percent 
analgesic activity was calculated by the formula given as
%Analgesic activity = [(T2-T1)/(Tc-T1)]x100  [4]
where T1 - the reaction time (s) before administration of 
prodrug and  T2 -the reaction time (s) after administration 
of prodrug and Tc - cutoff time in sec.
2.5.3. Ulcerogenic activity
Gastrointestinal toxicity of the synthesized prodrugs 
was measured and compared with the parent drug by 
measuring ulcer index18. The prodrug was suspended in 
10 ml of 2% w/v suspension of acacia. Measured volume 
of the suspension containing AC was administered orally 
to the test group daily for 5 days. The albino rats (100-
200 g) were fasted after the administration of last dose, 
thereafter they were sacrificed by decapitation and the 
stomach was removed, opened and washed with distilled 
water. The lesions on the gastric mucosa were counted by 
visual examination using a binocular magnifier. Ulcers 
greater than 0.5 mm were recorded. The ulcer index (UI) 
was calculated by severity of gastric mucosal lesions which 
are graded as grade1 - less than1mm erosions, grade 2 - 1-2 
mm erosions and grade 3 - more than 2 mm erosions. The 
UI was calculated as:
UI = [1×(number of lesions of grade 1)+2×(number 
of lesions of grade 2)+3×(number of lesions of grade 
3)]/10     [6]
2.5.4. Histopathological studies
The histopathological studies19 of stomach of rats were 
carried out using haemotoxylin and eosin stain at Pathology 
Department, Sri Venkateswara Veterinary University, 
Tirupati, India. The stomach tissues were removed from 
the rats and fixed in 10% normal saline for at least 48 h. 
These were then processed routinely and the tissues were 
embedded in paraffin wax. Histological sections were cut 
at 5-6 μm and stained with routine haematoxylin and eosin. 
These were then examined by a consultant histopathologist. 
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Table 1: Physicochemical properties of prodrugs






Calculated (%) Found (%)
AC10 White 193-194 95.50 0.58 13.3 0.028 11250 13240
AC20 White 196-198 97.00 0.57 16 0.035 21950 25260
* Uncorrected     # Acetone: chloroform: acetic acid: water in 3:2:1:4
a = amount of parent drug in mg per 100 mg of prodrug
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The lesions observed were assessed for the following 
mucosal atrophy, the presence of inflammatory cells in 
the wall, oesinophils, lymphocytes and plasma cells. 
Photomicrographs of representative lesions at various 
magnifications were taken on Zeiss optical microscope 
(Germany), Stemi 2000-C, with a resolution of 10x40X, 
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Figure 1. Comparative pattern of hydrolysis of 
prodrugs in (a) SGF (b) SIF and (c) SCF
AC10
AC20



































































attached with trinocular camera. 
Statistical analysis 
Statistical analysis of the pharmacological activity of the 
synthesized prodrugs on animals was evaluated using a 
one-way analysis of variance (ANOVA).  Student’s t-test was 
applied for expressing the significance and the experimental 
data are expressed as mean ± SD (standard deviation).
RESULTS AND DISCUSSION
The synthesis of polymeric prodrugs AC10 and AC20 were 
carried out successfully. The prodrugs were subjected 
to physicochemical characterization, hydrolytic studies 
and pharmacological evaluation. The physicochemical 
properties are shown in table 1. The structure of synthesized 
prodrugs was confirmed by analytical and spectral data. 
The NMR spectra of AC prodrugs showed characteristic 
shifting of glucocidic ring anomeric proton signals from δ 
3.63 (H-1) to δ 5.30 (H-1), H-2 proton from δ 2.0 (H-2) to δ 
3.89 (H-2) which indicates the formation of an ester linkage 
at position C2. The disappearance of NMR signals in the 
range of δ 10.58 to δ 11.20 ppm for carboxylic acid group in 
the AC dextran prodrugs suggests that the free carboxylic 
acid group of drug was conjugated with hydroxyl group 
of dextran macromolecule and ester bond was formed. 
The signals of the aromatic ring of AC were found as δ 
7.25 and are in agreement with the anticipated structure. 
The IR spectra of the AC prodrugs showed characteristic 
stretching at 1736 cm-1 and confirm the formation of ester 
linkage. A strong O-H stretching vibration of polymeric 
association at 3421 cm-1 and weak C-H stretching of 
allkane at 3070 cm-1 were also found. It also showed 
the characteristic absorption stretching at 1568 cm-1 for 
aromatic ring. An absorption maximum in phosphate 
buffer (pH 7.4) was observed at 230 nm which was same as 
that of AC. The degree of substitution was determined by 
UV spectrophotometry and was found as 13.3% for AC10 
and 16% for AC20.
In vitro hydrolytic studies were carried out in SGF (pH 
1.2), SIF (pH 7.4) and SCF (pH 6.8) and the results are 
summarized in Figs 1 and 2. The AC prodrugs did not 
show much significant hydrolysis in SGF (pH 1.2). The 
amount of AC regenerated by hydrolysis of AC10 and 
AC20 in SIF was found as 79.7 and 70.4% respectively, 
whereas 88 and 82% in SCF. The AC prodrugs showed 
much faster hydrolysis in SIF and SCF and followed first 
order kinetics. This encouraging hydrolysis is due to the 
cleavage of prodrug to drug with the help of enzymes like 
amidase and esterase present in the simulated fluids. The 
half lives of AC10 and AC20 were found to be 3.43 h and 
3.48 h respectively.
Synthesis and characterization of novel dextran-conjugated macromolecules of aceclofenac
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The synthesized prodrugs were subjected to 
pharmacological evaluation of anti- inflammatory activity, 
analgesia, ulcerogenicity and histopathology. The AC 
prodrugs showed improved anti-inflammatory and 
AC10
AC20
0       1        2        3       4        5       6        7        8       9
AC10: y= -0.0885x +2.0075
 R2=0.9925






























Figure 2. First order kinetics plot of AC10 and AC20 
in SCF (pH 6.8)
Figure 4.Histopathological findings of aceclofenac and its prodrugs on rat stomach. a) Healthy control b) Ulcer 
control showing mucosal injury characterized by AC and massive mucosal infiltration of inflammatory cell c) 
Treated with AC10 d) Treated with AC20


























analgesic activities as compared to the parent drug and 
are shown in table 2. After 6 h of administration of AC, 
the percentage anti-inflammatory activity was found as 
49.56 % whereas an improved value of 56.44 and 61.82% 
Rasheed A, Krishna U, Sivakrishna Reddy P and Mishra A 
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Table 2: Physicochemical properties of prodrugs
Group Prodrug 
Anti-inflammatory activity (%)b Analgesic activity (%)b
2 h 4 h 6 h 1 h 2 h 3 h 4 h
I ACa 42.31 ± 1.5 52.41 ± 1.2 49.56 ± 1.2 42.22± 1.5 55.1 ± 2.0 56.2 ± 1.1 54.41 ± 1.8
II AC10 46.41 ± 1.0*c 64.62 ± 1.3*c 56.44 ± 1.3*c 32.3 ± 1.7*c 57.5 ± 1.3*c 64.6 ± 2.3*c 69.53 ± 1.9*c
III AC20 46.21 ± 1.2*c 55.54 ± 1.1c 61.82 ± 1.8*c 38.1 ± 1.5*c 45.3 ± 1.2*c 59.1 ± 1.4*c 75.4 ± 1.4*c
aStandard drug (AC) was administered orally. bValues were expressed as mean ± SD of 6 observations. 
cComparison between Group I Vs Group II and III. 
Statistical significant test comparison was done by one way ANOVA followed by dunnet ‘t’
were obtained for AC10 and AC20 respectively. In case of 
analgesic activity, after 4 h of the administration of AC, the 
percentage analgesia was observed as 54.41% whereas an 
increased value of 69.53 and 75.4% was observed for the 
prodrugs. The parent drug AC has an ulcer index of 20 
where as AC10 and AC20 shows reduced ulcer index of 14 
and 9.8 respectively as depicted in Fig. 3. 
A normal histological finding was observed for the samples 
of the control group rats. Small hemorrhagic areas and 
patches of inflammatory cell infiltrations were present in 
the lumen of the glands and lamina propria when treated 
with parent drug, but normal histological findings were 
displayed for both AC10 and AC20 group. This reveals 
that the prodrugs are not producing much ulceration in the 
gastric region and are shown in Fig. 4.
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